User profiles for S Guerif
 | Sébastien GuérifUniversité Paris 13 - LIPN / UMR CNRS 7030 Verified email at lipn.univ-paris13.fr Cited by 193 |
An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer
…, SD Fosså, F Efficace, C Coens, S Guerif… - European journal of …, 2008 - Elsevier
… It was hypothesised that the QLQ-PR25 assesses HRQOL domains distinct from those
assessed by the QLQ-C30, and thus Pearson’s correlation coefficients of less than 0.40 were …
assessed by the QLQ-C30, and thus Pearson’s correlation coefficients of less than 0.40 were …
70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial
V Beckendorf, S Guerif, E Le Prisé, JM Cosset… - International Journal of …, 2011 - Elsevier
PURPOSE: To perform a randomized trial comparing 70 and 80 Gy radiotherapy for prostate
cancer. PATIENTS AND METHODS: A total of 306 patients with localized prostate cancer …
cancer. PATIENTS AND METHODS: A total of 306 patients with localized prostate cancer …
Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma …
…, S Sen, C Tuchais, O Dupuis, S Guerif… - The lancet …, 2012 - thelancet.com
Background Concomitant chemoradiotherapy and accelerated radiotherapy independently
improve outcomes for patients with locally advanced head and neck squamous-cell …
improve outcomes for patients with locally advanced head and neck squamous-cell …
Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a …
…, P Richaud, S Guerif, I Latorzeff, S Supiot… - The Lancet …, 2016 - thelancet.com
Background How best to treat rising prostate-specific antigen (PSA) concentration after
radical prostatectomy is an urgent clinical question. Salvage radiotherapy delays the need for …
radical prostatectomy is an urgent clinical question. Salvage radiotherapy delays the need for …
SAR405838: an optimized inhibitor of MDM2–p53 interaction that induces complete and durable tumor regression
…, A Aguilar, O Dos-Santos, L Besret, S Guerif… - Cancer research, 2014 - AACR
… Stéphane Guerif; Stéphane Guerif … S. Wang received commercial research grants from
Sanofi and Ascenta Therapeutics and has ownership interest in royalty of SAR405838. W. …
Sanofi and Ascenta Therapeutics and has ownership interest in royalty of SAR405838. W. …
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112 …
…, JP Suchaud, G Crehange, S Guerif… - The Lancet …, 2019 - thelancet.com
Background Radiotherapy is the standard salvage treatment after radical prostatectomy. To
date, the role of androgen deprivation therapy has not been formally shown. In this follow-up …
date, the role of androgen deprivation therapy has not been formally shown. In this follow-up …
Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of …
P Sargos, S Guerif, I Latorzeff, C Hennequin… - Cancer Treatment …, 2015 - Elsevier
Purpose Recommendations for pelvic lymph node (LN) contouring rely on relatively dated
studies that defined the Clinical Target Volume (CTV) of interest proposed for radiotherapy. …
studies that defined the Clinical Target Volume (CTV) of interest proposed for radiotherapy. …
The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity
V Beckendorf, S Guérif, E Le Prisé, JM Cosset… - International Journal of …, 2004 - Elsevier
PURPOSE: To describe treatments and acute tolerance in a randomized trial comparing 70
Gy and 80 Gy to the prostate in patients with localized prostate cancer. METHODS AND …
Gy and 80 Gy to the prostate in patients with localized prostate cancer. METHODS AND …
Discovery and optimization of pyrimidone indoline amide PI3Kβ inhibitors for the treatment of phosphatase and tensin homologue (PTEN)-deficient cancers
…, O Lemaitre, S Guerif, S Perron, S Monget… - Journal of medicinal …, 2014 - ACS Publications
… The (S)-methyl on the indoline 2 position of compound 28 is well-defined in the electron
density allowing for unambiguous assignment of the absolute stereochemistry for this compound…
density allowing for unambiguous assignment of the absolute stereochemistry for this compound…
Brachytherapy versus prostatectomy in localized prostate cancer: results of a French multicenter prospective medico-economic study
…, D Peiffert, M Delannes, T Flam, S Guerif… - International Journal of …, 2007 - Elsevier
… ’s and patient’s points of view concerning treatment-related symptoms. A total of 546 patients
(T1/T2N0M0 localized prostate cancer, PSA ≤20 ng/mL, biopsy Gleason score <8) were …
(T1/T2N0M0 localized prostate cancer, PSA ≤20 ng/mL, biopsy Gleason score <8) were …